Abstract. We begin a study of a pro-p analogue of limit groups via extensions of centralizers and call L this new class of pro-p groups. We show that the prop groups of L have finite cohomological dimension, type F P∞ and non-positive Euler characteristic. Among the group theoretic properties it is proved that they are free-by-(torsion-free poly -procyclic) and if non-abelian do not have a finitely generated non-trivial normal subgroup of infinite index. Furthermore it is shown that every
Abstract. We show that limit groups are free-by-(torsion-free nilpotent) and have non-positive Euler characteristic. We prove that for any non-abelian limit group the Bieri-NeumannStrebel-Renz S-invariants are the empty set.Let s d 3 be a natural number and G be a subdirect product of non-abelian limit groups intersecting each factor non-trivially. We show that the homology groups of any subgroup of finite index in G, in dimension i c s and with coe‰cients in Q, are finite-dimensional if and only if the projection of G to the direct product of any s of the limit groups has finite index.
Abstract. Thompson's group F is the group of all increasing dyadic PL homeomorphisms of the closed unit interval. We compute † m .F / and † m .F I Z/, the homotopical and homological Bieri-Neumann-Strebel-Renz invariants of F , and show thatAs an application, we show that, for every m, F has subgroups of type F m 1 which are not of type FP m (thus certainly not of type F m ).Mathematics Subject Classification (2010). 20J05, 20F65, 55U10.
Abstract. We show that Brin's generalisations 2V and 3V of the Thompson-Higman group V are of type FP∞. Our methods also give a new proof that both groups are finitely presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.